Herbal ingredients have been used in food and medicines and in cosmetic and domestic products since time immemorial. Hundreds of years on, they are still used for similar purposes – in herbal medicines, medical devices, botanical food supplements, cosmetic and bodycare products and biocidals – but each product type now has
its own distinct and particular legislative framework and rules.
Herbal product market analyses all point to growth, with just one sector alone, the global market for ‘herbal supplements and remedies’ being projected to exceed US$140 billion by 2024 – with Europe the largest market worldwide and China a close second.
Maximising success in an expanding herbal product market requires a clear understanding of the regulatory requirements for the various different categories of a product so as to assess what is and is not possible – and failure to undertake this essential groundwork can be costly in terms of both time and money.
This course will be of interest to a wide range of disciplines, including product managers and regulatory, technical and marketing staff: its content aims to encourage an objective view of not only current routes to market but also what other opportunities there might be – the strengths and weaknesses of what there is and how best to determine the reality of possible additions.
Routes to market for herbal products
Options and their legal/regulatory frameworks
Options and their legal/regulatory frameworks (continued)
Quality, safety and good manufacturing practice for:
Indications for use and health claims
The regulatory borderline
Summary of the day and final discussion session
After a career in industry as General Manger of a company making licensed natural medicines, food supplements and cosmetics, Penny Viner spent 7 years as Director of the Health Food Manufacturers’ Association (HFMA), whose members manufacture food and food supplement products, and remains its Vice President, with particular responsibility for herbal issues.
Penny also chairs the UK Herbal Forum, and is Director and Secretary of the British Association of Homoeopathic Manufacturers. Previously she was a Director and Secretary of the UK branch of the European Food Law Association.
She was a member of the British Pharmacopoeia Commission Expert Advisory Group on Herbal and Complementary Medicines and a member of the Ministerial Herbal Medicines and Practitioners Working Group, and is currently a member of MHRA’s Manufacturing Industry Liaison Group.
Until end 2013 she was a Project manager for the International Alliance of Dietary/Food Supplement Associations (IADSA), writing its monthly newsletter and coordinating its Scientific Group.
She now writes an International Regulatory Supplement for the European Federation of Associations of Health Product Manufacturers, is Vice-Chairman of its Botanicals Working Group, and is a botanicals expert for the European Botanical Forum.
Penny is also an independent consultant of food and medicines regulation.